Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01783197
Title Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group|AstraZeneca
Age Groups: adult
Covered Countries CAN

No variant requirements are available.